Genetic basis of attenuation of the Sabin type 3 oral poliovirus vaccine
- PMID: 2536836
- PMCID: PMC247831
- DOI: 10.1128/JVI.63.3.1338-1344.1989
Genetic basis of attenuation of the Sabin type 3 oral poliovirus vaccine
Abstract
The poliovirus type 3 Sabin oral poliovirus vaccine strain P3/Leon/12a1b differs in nucleotide sequence from its neurovirulent progenitor P3/Leon/37 by just 10 point mutations. The contribution of each mutation to the attenuation phenotype of the vaccine strain was determined by the construction of a series of recombinant viruses from infectious cDNA clones. The neurovirulence testing of recombinant viruses indicated that the attenuation phenotype is determined by just two point mutations: a C to U in the noncoding region at position 472 and a C to U at nucleotide 2034 which results in a serine-to-phenylalanine amino acid substitution in the structural protein VP3.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
